Q-Line Biotech IPO

The price band is ₹343 per share with a lot size of 400 shares. Minimum investment: ₹137200.

Q-Line Biotech Limited is engaged in the development, manufacturing, and marketing of diagnostic reagents, consumables, and in-vitro diagnostic (IVD) equipment for healthcare and diagnostic applications. The company supplies products such as clinical chemistry reagents, haematology and immunodiagnostic products, molecular diagnostic kits, rapid test kits, point-of-care devices, analysers, laboratory consumables, and diagnostic instruments to diagnostic laboratories, hospitals, and medical colleges. It also provides annual maintenance and after-sales services for medical equipment. During the Covid-19 pandemic, the company developed products including RT-PCR kits, RNA extraction kits, and VTM kits. Q-Line Biotech operates multiple manufacturing facilities, warehouses, and offices in Lucknow, Uttar Pradesh, Delhi, Kolkata and Bhubaneswar. Its manufacturing operations include indigenous production of reagents and diagnostic analysers, while some products are manufactured under technical collaborations with international companies.

Review the IPO's fundamentals, financials, and market conditions carefully. Always do your own research before investing.

Q-Line Biotech was founded by Mr Saurabh Garg in 2010.